New York Times Company (NYT) reported $3.05B of revenue for the twelve months ended Sep 30, 2026. That is up 10.8% from the year before. Revenue for fiscal 2025 was $2.82B.

Yes. New York Times Company earned $408.53M in net income for the twelve months ended Sep 30, 2026, a net margin of 13.4%.

How much cash and debt does NYT have?

New York Times Company reported $221.35M in cash and cash equivalents on its most recent balance sheet in SEC filings.

How fast is NYT revenue growing?

New York Times Company's revenue changed +9.2% in fiscal 2025, to $2.82B. Its compound annual growth rate was +9.6% over 5 years and +6.0% over 10 years.

What is NYT free cash flow?

New York Times Company generated $593.42M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $626.40M less capital expenditures.

What is NYT earnings per share?

Diluted earnings per share were $2.50 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.

When did NYT last report financial results?

The latest statements here come from New York Times Company's 10-Q filed on Nov 4, 2026, covering the period ended Sep 30, 2026.

Where does this NYT financial data come from?

Quantisnow builds these statements from the structured XBRL data New York Times Company files with the SEC. It is provided for information only and is not investment advice.

Financials · NYT

New York Times Company (NYT) financials

For the twelve months ended Sep 30, 2026, New York Times Company reported $3.05B of revenue and $408.53M of net income.

Revenue, TTM: $3.05B
Revenue growth, YoY: +10.8%
Net income, TTM: $408.53M
Net income growth, YoY: +20.9%
Net margin: 13.4%
Free cash flow, TTM: $593.42M
EPS, diluted, TTM: $2.50
EPS growth, YoY: +22.5%
Cash: $221.35M
P/E: 28.41
P/S: 3.81
Market cap: $11.61B

Annual revenue$2.82B

FY2016FY2025

Annual net income$343.98M

FY2016FY2025

Annual free cash flow$550.50M

FY2016FY2025

NYT revenue and earnings growth

NYT revenueQ3 2026$768.54M

Quarter YoY: +9.7%
QoQ: +0.8%
FY YoY: +9.2%
5Y CAGR: +9.6%
10Y CAGR: +6.0%

NYT revenue was $768.54M in fiscal Q3 2026 (ended Sep 30, 2026), up 9.7% from a year earlier and up 0.8% from the prior quarter. For the full fiscal 2025 it was $2.82B, up 9.2% from fiscal 2024. Compound annual growth was +9.6% over 5 years and +6.0% over 10 years. It rose in 8 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

NYT net incomeQ3 2026$97.36M

Quarter YoY: +19.2%
QoQ: +4.2%
FY YoY: +17.1%
5Y CAGR: +28.0%
10Y CAGR: +18.5%

NYT net income was $97.36M in fiscal Q3 2026 (ended Sep 30, 2026), up 19.2% from a year earlier and up 4.2% from the prior quarter. For the full fiscal 2025 it was $343.98M, up 17.1% from fiscal 2024. Compound annual growth was +28.0% over 5 years and +18.5% over 10 years. It rose in 6 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

NYT EPSQ3 2026$0.60

Quarter YoY: +20.0%
QoQ: +5.3%
FY YoY: +18.1%
5Y CAGR: +28.4%
10Y CAGR: +18.6%

NYT diluted EPS was $0.60 in fiscal Q3 2026 (ended Sep 30, 2026), up 20.0% from a year earlier and up 5.3% from the prior quarter. For the full fiscal 2025 it was $2.09, up 18.1% from fiscal 2024. Compound annual growth was +28.4% over 5 years and +18.6% over 10 years.

NYT free cash flowQ3 2026$170.14M

Quarter YoY: -14.8%
QoQ: -7.6%
FY YoY: +44.4%
5Y CAGR: +15.9%
10Y CAGR: +13.7%

NYT free cash flow was $170.14M in fiscal Q3 2026 (ended Sep 30, 2026), down 14.8% from a year earlier and down 7.6% from the prior quarter. For the full fiscal 2025 it was $550.50M, up 44.4% from fiscal 2024. Compound annual growth was +15.9% over 5 years and +13.7% over 10 years. It rose in 6 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

Export CSV

Income statement

Income statement
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 26, 2021	FY2020 Dec 27, 2020	FY2019 Dec 29, 2019	FY2018 Dec 30, 2018	FY2017 Dec 31, 2017	FY2016 Dec 25, 2016
Revenue	$2.82B	$2.59B	$2.43B	$2.31B	$2.07B	$1.78B	$1.81B	$1.75B	$1.68B	$1.56B
Cost of revenue	-	-	-	-	-	-	$0	$0	$616.34M	$629.36M
Gross profit	-	-	-	-	-	-	$1.81B	$1.75B	$1.06B	$925.99M
Research and development	$264.35M	$248.20M	$228.80M	$204.19M	$160.87M	$133.38M	$106.42M	$84.10M	-	-
Selling, general and admin	$328.06M	$307.93M	$311.04M	$289.26M	$250.12M	$223.56M	$206.78M	$0	$815.07M	$728.34M
Operating income	$431.56M	$351.10M	$276.27M	$201.97M	$268.03M	$176.26M	$175.58M	$190.17M	$176.59M	$112.68M
Pre-tax income	$451.26M	$383.42M	$302.59M	$236.00M	$290.50M	$115.43M	$164.46M	$176.09M	$111.22M	$30.53M
Income tax	$107.28M	$89.60M	$69.84M	$62.09M	$70.53M	$14.60M	$24.49M	$48.63M	$103.96M	$4.42M
Net income	$343.98M	$293.82M	$232.39M	$173.91M	$219.97M	$100.10M	$139.97M	$125.68M	$4.30M	$29.07M
EPS, basic	$2.11	$1.79	$1.41	$1.04	$1.31	$0.60	$0.84	$0.76	$0.03	$0.18
EPS, diluted	$2.09	$1.77	$1.40	$1.04	$1.31	$0.60	$0.83	$0.75	$0.03	$0.18
Diluted shares	164.9M	165.8M	165.7M	167.1M	168.5M	168.0M	167.5M	166.9M	164.3M	162.8M

Balance sheet

Balance sheet
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 26, 2021	FY2020 Dec 27, 2020	FY2019 Dec 29, 2019	FY2018 Dec 30, 2018	FY2017 Dec 31, 2017	FY2016 Dec 25, 2016
Cash and equivalents	$255.44M	$213.86M	$303.17M	$235.17M	$334.31M	$301.96M	$247.52M	$259.80M	$200.94M	$125.55M
Short-term investments	$386.71M	$366.47M	$162.09M	$125.97M	$341.07M	$309.08M	$201.78M	$371.30M	$308.59M	$449.54M
Receivables	$290.82M	$249.53M	$242.49M	$217.53M	$232.91M	$183.69M	$213.40M	$222.46M	$184.88M	$197.35M
Current assets	$1.03B	$936.32M	$781.65M	$655.67M	$952.71M	$835.84M	$716.83M	$893.95M	$749.70M	$796.18M
Goodwill	$409.21M	$412.17M	$416.10M	$414.05M	$166.36M	$171.66M	$138.67M	$140.28M	$143.55M	$134.52M
Total assets	$3.00B	$2.84B	$2.71B	$2.53B	$2.56B	$2.31B	$2.09B	$2.20B	$2.10B	$2.19B
Current liabilities	$666.70M	$613.53M	$611.56M	$571.21M	$559.15M	$486.75M	$437.69M	$673.30M	$415.66M	$398.74M
Short-term debt	-	-	-	-	-	-	$0	$253.63M	$0	-
Long-term debt	-	-	-	-	-	-	-	$247.00M	$243.00M	$240.20M
Total debt	-	-	-	-	-	-	-	$500.63M	$243.00M	$240.20M
Total liabilities	$955.73M	$914.27M	$951.38M	$933.78M	$1.02B	$979.58M	$915.27M	$1.15B	$1.20B	$1.34B
Shareholders' equity	$2.04B	$1.93B	$1.76B	$1.60B	$1.54B	$1.33B	$1.17B	$1.04B	$897.36M	$844.24M

Cash flow

Cash flow
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 26, 2021	FY2020 Dec 27, 2020	FY2019 Dec 29, 2019	FY2018 Dec 30, 2018	FY2017 Dec 31, 2017	FY2016 Dec 25, 2016
Operating cash flow	$584.49M	$410.51M	$360.62M	$150.69M	$269.10M	$297.93M	$189.90M	$157.12M	$86.71M	$103.88M
Capital expenditures	$33.98M	$29.17M	$22.67M	$36.96M	$34.64M	$34.45M	$45.44M	$77.49M	$84.75M	$30.09M
Free cash flow	$550.50M	$381.34M	$337.95M	$113.73M	$234.46M	$263.48M	$144.46M	$79.63M	$1.96M	$73.78M
Investing cash flow	-$221.32M	-$306.09M	-$159.69M	-$73.56M	-$180.81M	-$199.08M	$93.21M	-$101.09M	$14.10M	$124.47M
Financing cash flow	-$306.14M	-$192.72M	-$132.71M	-$174.31M	-$54.95M	-$44.97M	-$295.29M	$3.82M	-$26.02M	-$237.02M
Dividends paid	$110.36M	$82.86M	$69.46M	$56.79M	$45.34M	$38.44M	$31.60M	$26.42M	$26.00M	$25.90M
Share repurchases	$165.34M	$85.04M	$44.55M	$105.06M	$0	$0	-	$0	$0	$15.68M
Stock-based compensation	$74.18M	$67.50M	$54.78M	$35.31M	$22.21M	$14.44M	$12.95M	$12.96M	$14.81M	$12.43M
Depreciation and amortization	$85.01M	$82.94M	$86.11M	$82.65M	$57.50M	$62.14M	$60.66M	$59.01M	$61.87M	$61.72M

Key ratios

Key ratios
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 26, 2021	FY2020 Dec 27, 2020	FY2019 Dec 29, 2019	FY2018 Dec 30, 2018	FY2017 Dec 31, 2017	FY2016 Dec 25, 2016
Revenue growth, YoY	9.2%	6.6%	5.1%	11.3%	16.3%	-1.6%	3.6%	4.4%	7.7%	-1.5%
Net income growth, YoY	17.1%	26.4%	33.6%	-20.9%	119.7%	-28.5%	11.4%	2825.6%	-85.2%	-54.0%
EPS growth, YoY	18.1%	26.4%	34.6%	-20.6%	118.3%	-27.7%	10.7%	2400.0%	-83.3%	-52.6%
Gross margin	-	-	-	-	-	-	100.0%	100.0%	63.2%	59.5%
Operating margin	15.3%	13.6%	11.4%	8.7%	12.9%	9.9%	9.7%	10.9%	10.5%	7.2%
Net margin	12.2%	11.4%	9.6%	7.5%	10.6%	5.6%	7.7%	7.2%	0.3%	1.9%
Free cash flow margin	19.5%	14.7%	13.9%	4.9%	11.3%	14.8%	8.0%	4.6%	0.1%	4.7%
Return on equity	16.9%	15.2%	13.2%	10.9%	14.3%	7.5%	11.9%	12.1%	0.5%	3.4%
Return on assets	11.5%	10.3%	8.6%	6.9%	8.6%	4.3%	6.7%	5.7%	0.2%	1.3%
Current ratio	1.54	1.53	1.28	1.15	1.70	1.72	1.64	1.33	1.80	2.00
Debt to equity	-	-	-	-	-	-	-	0.48	0.27	0.28

Income statement

Income statement
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue	$768.54M	$762.46M	$712.24M	$802.31M	$700.82M	$685.87M	$635.91M	$726.63M	$640.18M	$625.10M	$594.01M	$676.22M
Research and development	$72.28M	$70.35M	$70.19M	$66.88M	$66.99M	$63.94M	$66.54M	$61.76M	$61.03M	$62.22M	$63.19M	$58.26M
Selling, general and admin	$86.38M	$85.77M	$86.45M	$88.96M	$76.64M	$82.55M	$79.91M	$76.04M	$76.21M	$76.87M	$78.81M	$75.84M
Operating income	$121.94M	$118.02M	$90.62M	$161.58M	$104.79M	$106.55M	$58.63M	$146.64M	$76.73M	$79.41M	$48.32M	$129.03M
Pre-tax income	$129.88M	$125.22M	$98.32M	$167.63M	$108.00M	$111.66M	$63.97M	$155.64M	$85.04M	$87.08M	$55.66M	$139.87M
Income tax	$32.52M	$31.80M	$10.40M	$37.79M	$26.35M	$28.72M	$14.42M	$31.92M	$20.90M	$21.54M	$15.24M	$29.63M
Net income	$97.36M	$93.42M	$87.92M	$129.84M	$81.65M	$82.94M	$49.55M	$123.72M	$64.14M	$65.54M	$40.42M	$109.88M
EPS, basic	$0.60	$0.58	$0.54	$0.80	$0.50	$0.51	$0.30	$0.75	$0.39	$0.40	$0.25	$0.66
EPS, diluted	$0.60	$0.57	$0.54	$0.79	$0.50	$0.50	$0.30	$0.74	$0.39	$0.40	$0.24	$0.67
Diluted shares	162.3M	163.0M	163.7M	-	164.4M	164.3M	164.9M	-	165.8M	165.5M	165.6M	-

Balance sheet

Balance sheet
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Cash and equivalents	$221.35M	$232.66M	$186.73M	$255.44M	$249.34M	$198.24M	$182.60M	$213.86M	$204.62M	$222.95M	$206.82M	$303.17M
Short-term investments	$451.52M	$428.15M	$407.79M	$386.71M	$368.01M	$342.00M	$339.48M	$366.47M	$288.32M	$188.44M	$172.24M	$162.09M
Receivables	$248.75M	$236.03M	$234.86M	$290.82M	$204.09M	$211.08M	$192.51M	$249.53M	$188.95M	$181.28M	$177.66M	$242.49M
Current assets	$1.05B	$1.02B	$927.21M	$1.03B	$938.30M	$855.00M	$801.57M	$936.32M	$794.98M	$716.15M	$681.16M	$781.65M
Goodwill	$406.81M	$407.20M	$407.79M	$409.21M	$409.19M	$409.23M	$414.80M	$412.17M	$416.78M	$414.16M	$414.63M	$416.10M
Total assets	$3.02B	$2.98B	$2.86B	$3.00B	$2.89B	$2.81B	$2.74B	$2.84B	$2.76B	$2.67B	$2.62B	$2.71B
Current liabilities	$685.65M	$647.72M	$577.88M	$666.70M	$615.49M	$577.99M	$554.85M	$613.53M	$589.60M	$543.13M	$544.72M	$611.56M
Total liabilities	-	-	-	$955.73M	-	-	-	$914.27M	$910.05M	$868.38M	$874.86M	$951.38M
Shareholders' equity	$2.05B	$2.05B	$2.00B	$2.04B	$1.98B	$1.94B	$1.88B	$1.93B	$1.85B	$1.80B	$1.75B	$1.76B

Cash flow

Cash flow
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Operating cash flow	$175.75M	$194.26M	$92.24M	$164.16M	$207.61M	$113.64M	$99.09M	$151.70M	$125.51M	$80.23M	$53.08M	$136.52M
Capital expenditures	$5.61M	$10.11M	$10.72M	$6.53M	$7.88M	$10.34M	$9.24M	$8.06M	$7.06M	$7.63M	$6.42M	$6.13M
Free cash flow	$170.14M	$184.15M	$81.51M	$157.62M	$199.73M	$103.30M	$89.85M	$143.64M	$118.44M	$72.60M	$46.66M	$130.39M
Investing cash flow	-$69.68M	-$74.06M	-$22.68M	-$72.20M	-$97.03M	-$43.74M	-$8.34M	-$108.63M	-$101.29M	-$29.78M	-$66.39M	-$62.40M
Financing cash flow	-$117.86M	-$73.69M	-$139.16M	-$85.41M	-$58.97M	-$54.48M	-$107.27M	-$48.07M	-$42.30M	-$33.66M	-$68.68M	-$20.89M
Dividends paid	$37.21M	$37.19M	$30.39M	$29.29M	$29.40M	$29.60M	$22.07M	$21.36M	$21.47M	$21.41M	$18.62M	$18.10M
Share repurchases	$79.10M	$35.43M	$56.35M	$55.46M	$27.32M	$23.60M	$58.96M	$24.70M	$18.34M	$9.55M	$32.46M	$962.0K
Stock-based compensation	$19.13M	$19.99M	$19.27M	$20.52M	$18.51M	$17.80M	$17.35M	$17.62M	$16.99M	$17.03M	$15.86M	$16.06M
Depreciation and amortization	$21.14M	$21.12M	$20.56M	$20.89M	$21.34M	$21.40M	$21.38M	$21.07M	$20.62M	$20.54M	$20.71M	$21.94M

Key ratios

Key ratios
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue growth, YoY	9.7%	11.2%	12.0%	10.4%	9.5%	9.7%	7.1%	7.5%	7.0%	5.8%	5.9%	1.3%
Net income growth, YoY	19.2%	12.6%	77.4%	4.9%	27.3%	26.6%	22.6%	12.6%	19.6%	40.7%	81.1%	55.2%
EPS growth, YoY	20.0%	14.0%	80.0%	6.8%	28.2%	25.0%	25.0%	10.4%	21.9%	42.9%	84.6%	59.5%
Operating margin	15.9%	15.5%	12.7%	20.1%	15.0%	15.5%	9.2%	20.2%	12.0%	12.7%	8.1%	19.1%
Net margin	12.7%	12.3%	12.3%	16.2%	11.7%	12.1%	7.8%	17.0%	10.0%	10.5%	6.8%	16.2%
Free cash flow margin	22.1%	24.2%	11.4%	19.6%	28.5%	15.1%	14.1%	19.8%	18.5%	11.6%	7.9%	19.3%
Current ratio	1.52	1.58	1.60	1.54	1.52	1.48	1.44	1.53	1.35	1.32	1.25	1.28

Source: XBRL data New York Times Company files with the SEC, latest filing dated Nov 4, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

NYT peers

Company	Revenue	Growth	Net income	Net margin	Market cap
NYT	$3.05B	+10.8%	$408.53M	13.4%	$11.61B
NWSNews Corporation	$9.16B	+7.8%	$620.00M	6.8%	$16.01B
NWSANews Corporation	$9.16B	+7.8%	$620.00M	6.8%	$14.29B
TDAYUSA TODAY Co. Inc.	$2.19B	-6.4%	-$5.65M	-0.3%	$1.03B
DJCODaily Journal Corp. (S.C.)	$97.64M	+23.4%	-$11.36M	-11.6%	$923.9M
LEELee Enterprises Incorporated	$517.10M	-11.1%	-$8.57M	-1.7%	$155.8M

NYT FAQ

8 questions

What is NYT revenue?
New York Times Company (NYT) reported $3.05B of revenue for the twelve months ended Sep 30, 2026. That is up 10.8% from the year before. Revenue for fiscal 2025 was $2.82B.
Is NYT profitable?
Yes. New York Times Company earned $408.53M in net income for the twelve months ended Sep 30, 2026, a net margin of 13.4%.
How much cash and debt does NYT have?
New York Times Company reported $221.35M in cash and cash equivalents on its most recent balance sheet in SEC filings.
How fast is NYT revenue growing?
New York Times Company's revenue changed +9.2% in fiscal 2025, to $2.82B. Its compound annual growth rate was +9.6% over 5 years and +6.0% over 10 years.
What is NYT free cash flow?
New York Times Company generated $593.42M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $626.40M less capital expenditures.
What is NYT earnings per share?
Diluted earnings per share were $2.50 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
When did NYT last report financial results?
The latest statements here come from New York Times Company's 10-Q filed on Nov 4, 2026, covering the period ended Sep 30, 2026.
Where does this NYT financial data come from?
Quantisnow builds these statements from the structured XBRL data New York Times Company files with the SEC. It is provided for information only and is not investment advice.